{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T18:56:51Z","timestamp":1789585011171,"version":"build-2803163510"},"reference-count":102,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Respir Res"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1186\/1465-9921-12-45","type":"journal-article","created":{"date-parts":[[2011,4,12]],"date-time":"2011-04-12T06:20:37Z","timestamp":1302589237000},"source":"Crossref","is-referenced-by-count":45,"title":["Prospect of vasoactive intestinal peptide therapy for COPD\/PAH and asthma: a review"],"prefix":"10.1186","volume":"12","author":[{"given":"Dongmei","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongwon","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong Kiel","family":"Sung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,12,1]]},"reference":[{"key":"1073_CR1","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1126\/science.169.3951.1217","volume":"169","author":"SI Said","year":"1970","unstructured":"Said SI, Mutt V: Polypeptide with broad biological activity: isolation from small intestine. Science. 1970, 169: 1217-8. 10.1126\/science.169.3951.1217.","journal-title":"Science"},{"key":"1073_CR2","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/BF03348097","volume":"9","author":"SI Said","year":"1986","unstructured":"Said SI: Vasoactive intestinal peptide. J Endocrinol Invest. 1986, 9: 191-200.","journal-title":"J Endocrinol Invest"},{"key":"1073_CR3","doi-asserted-by":"crossref","first-page":"44S","DOI":"10.1016\/S0012-3692(15)53085-7","volume":"67","author":"SI Said","year":"1975","unstructured":"Said SI, Mutt V, Yoshida T, Hara N: Vasoactive polypeptides from normal lung. Chest. 1975, 67: 44S-10.1378\/chest.67.2_Supplement.44S.","journal-title":"Chest"},{"key":"1073_CR4","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1210\/endo-111-4-1248","volume":"111","author":"MA Ghatei","year":"1982","unstructured":"Ghatei MA, Sheppard MN, O'Shaughnessy DJ, Adrian TE, McGregor GP, Polak JM, Bloom SR: Regulatory peptides in the mammalian respiratory tract. Endocrinology. 1982, 111: 1248-54. 10.1210\/endo-111-4-1248.","journal-title":"Endocrinology"},{"key":"1073_CR5","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1172\/JCI114780","volume":"86","author":"JN Baraniuk","year":"1990","unstructured":"Baraniuk JN, Lundgren JD, Okayama M, Mullol J, Merida M, Shelhamer JH, Kaliner MA: Vasoactive intestinal peptide in human nasal mucosa. J Clin Invest. 1990, 86: 825-31. 10.1172\/JCI114780.","journal-title":"J Clin Invest"},{"key":"1073_CR6","first-page":"E33","volume":"9","author":"MC Dvor\u00e1kov\u00e1","year":"2005","unstructured":"Dvor\u00e1kov\u00e1 MC: Cardioprotective role of the VIP signaling system. Timely Top Med Cardiovasc Dis. 2005, 9: E33-","journal-title":"Timely Top Med Cardiovasc Dis"},{"key":"1073_CR7","first-page":"304","volume":"97","author":"T Saga","year":"1984","unstructured":"Saga T, Said SI: Vasoactive intestinal peptide relaxes isolated strips of human bronchus, pulmonary artery, and lung parenchyma. Trans Assoc Am Physicians. 1984, 97: 304-10.","journal-title":"Trans Assoc Am Physicians"},{"key":"1073_CR8","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/j.1365-2249.2009.03956.x","volume":"157","author":"SG Smalley","year":"2009","unstructured":"Smalley SG, Barrow PA, Foster N: Immunomodulation of innate immune responses by vasoactive intestinal peptide (VIP): its therapeutic potential in inflammatory disease. Clin Exp Immunol. 2009, 157: 225-34. 10.1111\/j.1365-2249.2009.03956.x.","journal-title":"Clin Exp Immunol"},{"key":"1073_CR9","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.ejps.2010.08.007","volume":"41","author":"S Onoue","year":"2010","unstructured":"Onoue S, Misaka S, Aoki Y, Karaki S, Kuwahara A, Ohide A, Mizumoto T, Yamada S: Inhalable powder formulation of vasoactive intestinal peptide derivative, [R15,20,21, L17]-VIP-GRR, attenuated neutrophilic airway inflammation in cigarette smoke-exposed rats. Eur J Pharm Sci. 2010, 41: 508-14. 10.1016\/j.ejps.2010.08.007.","journal-title":"Eur J Pharm Sci"},{"key":"1073_CR10","doi-asserted-by":"crossref","first-page":"L880","DOI":"10.1152\/ajplung.00499.2005","volume":"291","author":"AM Szema","year":"2006","unstructured":"Szema AM, Hamidi SA, Lyubsky S, Dickman KG, Mathew S, Abdel-Razek T, Chen JJ, Waschek JA, Said SI: Mice lacking the VIP gene show airway hyperresponsiveness and airway inflammation, partially reversible by VIP. Am J Physiol Lung Cell Mol Physiol. 2006, 291: L880-6. 10.1152\/ajplung.00499.2005.","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"1073_CR11","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1016\/j.peptides.2007.04.009","volume":"28","author":"S Onoue","year":"2007","unstructured":"Onoue S, Yamada S, Yajima T: Bioactive analogues and drug delivery systems of vasoactive intestinal peptide (VIP) for the treatment of asthma\/COPD. Peptides. 2007, 28: 1640-50. 10.1016\/j.peptides.2007.04.009.","journal-title":"Peptides"},{"key":"1073_CR12","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1161\/01.CIR.0000156326.48823.55","volume":"111","author":"JX Yuan","year":"2005","unstructured":"Yuan JX, Rubin LJ: Pathogenesis of pulmonary arterial hypertension: the need for multiple hits. Circulation. 2005, 111: 534-8. 10.1161\/01.CIR.0000156326.48823.55.","journal-title":"Circulation"},{"key":"1073_CR13","first-page":"190","volume":"45","author":"R Gandhi","year":"2010","unstructured":"Gandhi R, Baker N, Shek A, Yeh J, Bishop D: Pulmonary arterial hypertension: bridging the gap between efficacy, quality of life, and cost-effectiveness. Formulary. 2010, 45: 190-199.","journal-title":"Formulary"},{"key":"1073_CR14","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s10557-006-0498-3","volume":"20","author":"M Sahara","year":"2006","unstructured":"Sahara M, Takahashi T, Imai Y, Nakajima T, Yao A, Morita T, Hirata Y, Nagai R: New insights in the treatment strategy for pulmonary arterial hypertension. Cardiovasc Drugs Ther. 2006, 20: 377-86. 10.1007\/s10557-006-0498-3.","journal-title":"Cardiovasc Drugs Ther"},{"key":"1073_CR15","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/S0140-6736(07)61380-4","volume":"370","author":"DM Mannino","year":"2007","unstructured":"Mannino DM, Buist AS: Global burden of COPD: risk factors, prevalence, and future trends. Lancet. 2007, 370: 765-73. 10.1016\/S0140-6736(07)61380-4.","journal-title":"Lancet"},{"key":"1073_CR16","doi-asserted-by":"crossref","first-page":"2","DOI":"10.3810\/pgm.12.2005.suppl44.232","volume":"118","author":"WE Berger","year":"2005","unstructured":"Berger WE, Cline DC: Asthma and COPD: definitions, epidemiology, and treatment guidelines. Postgrad Med. 2005, 118: 2-8. 10.3810\/pgm.12.2005.suppl44.232.","journal-title":"Postgrad Med"},{"key":"1073_CR17","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0031-6997(25)06937-6","volume":"48","author":"JM Lundberg","year":"1996","unstructured":"Lundberg JM: Pharmacology of cotransmission in the autonomic nervous system: integrative aspects on amines, neuropeptides, adenosine triphosphate, amino acids and nitric oxide. Pharmacol Rev. 1996, 48: 113-78.","journal-title":"Pharmacol Rev"},{"key":"1073_CR18","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0008-6363(00)00229-7","volume":"49","author":"RJ Henning","year":"2001","unstructured":"Henning RJ, Sawmiller DR: Vasoactive intestinal peptide: cardiovascular effects. Cardiovasc Res. 2001, 49: 27-37. 10.1016\/S0008-6363(00)00229-7.","journal-title":"Cardiovasc Res"},{"key":"1073_CR19","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/0306-4522(83)90177-X","volume":"9","author":"NG Della","year":"1983","unstructured":"Della NG, Papka RE, Furness JB, Costa M: Vasoactive intestinal peptide-like immunoreactivity in nerves associated with the cardiovascular system of guinea-pigs. Neuroscience. 1983, 9: 605-19. 10.1016\/0306-4522(83)90177-X.","journal-title":"Neuroscience"},{"key":"1073_CR20","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/S0735-1097(86)80513-7","volume":"7","author":"JM Brum","year":"1986","unstructured":"Brum JM, Bove AA, Sufan Q, Reilly W, Go VL: Action and localization of vasoactive intestinal peptide in the coronary circulation: evidence for nonadrenergic, noncholinergic coronary regulation. J Am Coll Cardiol. 1986, 7: 406-13. 10.1016\/S0735-1097(86)80513-7.","journal-title":"J Am Coll Cardiol"},{"key":"1073_CR21","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1023\/A:1022431011019","volume":"22","author":"J Slav\u00edkov\u00e1","year":"1997","unstructured":"Slav\u00edkov\u00e1 J: Distribution of peptide-containing neurons in the developing rat right atrium, studied using immunofluorescence and confocal laser scanning. Neurochem Res. 1997, 22: 1013-21.","journal-title":"Neurochem Res"},{"key":"1073_CR22","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0940-9602(03)80079-1","volume":"185","author":"J Kuncov\u00e1","year":"2003","unstructured":"Kuncov\u00e1 J, Slav\u00edkov\u00e1 J, Reischig J: Distribution of vasoactive intestinal polypeptide in the rat heart: effect of guanethidine and capsaicin. Ann Anat. 2003, 185: 153-61.","journal-title":"Ann Anat"},{"key":"1073_CR23","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/0163-7258(89)90129-0","volume":"41","author":"J Fahrenkrug","year":"1989","unstructured":"Fahrenkrug J: VIP and autonomic neurotransmission. Pharmacol Ther. 1989, 41: 515-34. 10.1016\/0163-7258(89)90129-0.","journal-title":"Pharmacol Ther"},{"key":"1073_CR24","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.ejphar.2005.12.055","volume":"533","author":"DA Groneberg","year":"2006","unstructured":"Groneberg DA, Rabe KF, Fischer A: Novel concepts of neuropeptide-based drug therapy: vasoactive intestinal polypeptide and its receptors. Eur J Pharmacol. 2006, 533: 182-94. 10.1016\/j.ejphar.2005.12.055.","journal-title":"Eur J Pharmacol"},{"key":"1073_CR25","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/BF00210505","volume":"220","author":"RD Dey","year":"1981","unstructured":"Dey RD, Shannon WA, Said SI: Localization of VIP-immunoreactive nerves in airways and pulmonary vessels of dogs, cat, and human subjects. Cell Tissue Res. 1981, 220: 231-8.","journal-title":"Cell Tissue Res"},{"key":"1073_CR26","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/0196-9781(84)90090-1","volume":"5","author":"JM Lundberg","year":"1984","unstructured":"Lundberg JM, Fahrenkrug J, H\u00f6kfelt T, Martling CR, Larsson O, Tatemoto K, Angg\u00e5rd A: Co-existence of peptide HI (PHI) and VIP in nerves regulating blood flow and bronchial smooth muscle tone in various mammals including man. Peptides. 1984, 5: 593-606. 10.1016\/0196-9781(84)90090-1.","journal-title":"Peptides"},{"key":"1073_CR27","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/BF00494059","volume":"82","author":"A Laitinen","year":"1985","unstructured":"Laitinen A, Partanen M, Hervonen A, Pelto-Huikko M, Laitinen LA: VIP like immunoreactive nerves in human respiratory tract. Light and electron microscopic study. Histochemistry. 1985, 82: 313-9. 10.1007\/BF00494059.","journal-title":"Histochemistry"},{"key":"1073_CR28","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1164\/ajrccm.154.1.8680682","volume":"154","author":"A Fischer","year":"1996","unstructured":"Fischer A, Hoffmann B: Nitric oxide synthase in neurons and nerve fibers of lower airways and in vagal sensory ganglia of man. Correlation with neuropeptides. Am J Respir Crit Care Med. 1996, 154: 209-16.","journal-title":"Am J Respir Crit Care Med"},{"key":"1073_CR29","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1002\/(SICI)1096-9861(19980511)394:3<326::AID-CNE4>3.0.CO;2-3","volume":"394","author":"A Fischer","year":"1998","unstructured":"Fischer A, Canning BJ, Undem BJ, Kummer W: Evidence for an esophageal origin of VIP-IR and NO synthase-IR nerves innervating the guinea pig trachealis: a retrograde neuronal tracing and immunohistochemical analysis. J Comp Neurol. 1998, 394: 326-34. 10.1002\/(SICI)1096-9861(19980511)394:3<326::AID-CNE4>3.0.CO;2-3.","journal-title":"J Comp Neurol"},{"key":"1073_CR30","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1111\/j.1749-6632.1996.tb17547.x","volume":"805","author":"A Fischer","year":"1996","unstructured":"Fischer A, Canning BJ, Kummer W: Correlation of vasoactive intestinal peptide and nitric oxide synthase with choline acetyltransferase in the airway innervation. Ann N Y Acad Sci. 1996, 805: 717-22. 10.1111\/j.1749-6632.1996.tb17547.x.","journal-title":"Ann N Y Acad Sci"},{"key":"1073_CR31","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/BF00239446","volume":"258","author":"A Luts","year":"1989","unstructured":"Luts A, Sundler F: Peptide-containing nerve fibers in the respiratory tract of the ferret. Cell Tissue Res. 1989, 258: 259-67. 10.1007\/BF00239446.","journal-title":"Cell Tissue Res"},{"key":"1073_CR32","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/275661a0","volume":"275","author":"E Cutz","year":"1978","unstructured":"Cutz E, Chan W, Track NS, Goth A, Said SI: Release of vasoactive intestinal polypeptide in mast cells by histamine liberators. Nature. 1978, 275: 661-2. 10.1038\/275661a0.","journal-title":"Nature"},{"key":"1073_CR33","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1016\/S0006-291X(87)80293-0","volume":"148","author":"J Aliakbari","year":"1987","unstructured":"Aliakbari J, Sreedharan SP, Turck CW, Goetzl EJ: Selective localization of vasoactive intestinal peptide and substance P in human eosinophils. Biochem Biophys Res Commun. 1987, 148: 1440-5. 10.1016\/S0006-291X(87)80293-0.","journal-title":"Biochem Biophys Res Commun"},{"key":"1073_CR34","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/0165-5728(94)90164-3","volume":"52","author":"A Metwali","year":"1994","unstructured":"Metwali A, Blum AM, Ferraris L, Klein JS, Fiocchi C, Weinstock JV: Eosinophils within the healthy or inflamed human intestine produce substance P and vasoactive intestinal peptide. J Neuroimmunol. 1994, 52: 69-78. 10.1016\/0165-5728(94)90164-3.","journal-title":"J Neuroimmunol"},{"key":"1073_CR35","first-page":"666","volume":"96","author":"MS O'Dorisio","year":"1980","unstructured":"O'Dorisio MS, O'Dorisio TM, Cataland S, Balcerzak SP: Vasoactive intestinal polypeptide as a biochemical marker for polymorphonuclear leukocytes. J Lab Clin Med. 1980, 96: 666-72.","journal-title":"J Lab Clin Med"},{"key":"1073_CR36","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1172\/JCI17500","volume":"111","author":"V Petkov","year":"2003","unstructured":"Petkov V, Mosgoeller W, Ziesche R, Raderer M, Stiebellehner L, Vonbank K, Funk GC, Hamilton G, Novotny C, Burian B, Block LH: Vasoactive intestinal peptide as a new drug for treatment of primary pulmonary hypertension. J Clin Invest. 2003, 111: 1339-46.","journal-title":"J Clin Invest"},{"key":"1073_CR37","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/sj.ejhg.5201711","volume":"15","author":"I Haberl","year":"2007","unstructured":"Haberl I, Frei K, Ramsebner R, Doberer D, Petkov V, Albinni S, Lang I, Lucas T, Mosgoeller W: Vasoactive intestinal peptide gene alterations in patients with idiopathic pulmonary arterial hypertension. Eur J Hum Genet. 2007, 15: 18-22. 10.1038\/sj.ejhg.5201711.","journal-title":"Eur J Hum Genet"},{"key":"1073_CR38","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/0196-9781(87)90183-5","volume":"8","author":"PK Opstad","year":"1987","unstructured":"Opstad PK: The plasma vasoactive intestinal peptide (VIP) response to exercise is increased after prolonged strain, sleep and energy deficiency and extinguished by glucose infusion. Peptides. 1987, 8: 175-8. 10.1016\/0196-9781(87)90183-5.","journal-title":"Peptides"},{"key":"1073_CR39","doi-asserted-by":"crossref","first-page":"807","DOI":"10.3109\/00365527809182195","volume":"13","author":"PG Burhol","year":"1978","unstructured":"Burhol PG, Lygren I, Waldum HL: Radioimmunoassay of vasoactive intestinal polypeptide in plasma. Scand J Gastroenterol. 1978, 13: 807-13. 10.3109\/00365527809182195.","journal-title":"Scand J Gastroenterol"},{"key":"1073_CR40","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/S0140-6736(73)91947-8","volume":"2","author":"SR Bloom","year":"1973","unstructured":"Bloom SR, Polak JM, Pearse AG: Vasoactive intestinal peptide and watery-diarrhoea syndrome. Lancet. 1973, 2: 14-6. 10.1016\/S0140-6736(73)91947-8.","journal-title":"Lancet"},{"key":"1073_CR41","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/0167-5273(96)02737-4","volume":"56","author":"M Gy\u00f6ngy\u00f6si","year":"1996","unstructured":"Gy\u00f6ngy\u00f6si M, N\u00e9meth J, V\u00e1rkonyi T: Elevated levels of plasma vasoactive intestinal peptide in human acute myocardial infarction. Int J Cardiol. 1996, 56: 159-61.","journal-title":"Int J Cardiol"},{"key":"1073_CR42","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1136\/gut.19.11.1049","volume":"19","author":"S Domschke","year":"1978","unstructured":"Domschke S, Domschke W, Bloom SR, Mitznegg P, Mitchell SJ, Lux G, Strunz U: Vasoactive intestinal peptide in man: pharmacokinetics, metabolic and circulatory effects. Gut. 1978, 19: 1049-53. 10.1136\/gut.19.11.1049.","journal-title":"Gut"},{"key":"1073_CR43","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1111\/j.1748-1716.1981.tb06840.x","volume":"112","author":"JM Lundberg","year":"1981","unstructured":"Lundberg JM, Fahrenkrug J, Brimijoin S: Characteristics of the axonal transport of vasoactive intestinal polypeptide (VIP) in nerves of the cat. Acta Physiol Scand. 1981, 112: 427-36. 10.1111\/j.1748-1716.1981.tb06840.x.","journal-title":"Acta Physiol Scand"},{"key":"1073_CR44","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/0196-9781(84)90197-9","volume":"5","author":"SI Said","year":"1984","unstructured":"Said SI: Vasoactive intestinal polypeptide (VIP): current status. Peptides. 1984, 5: 143-50. 10.1016\/0196-9781(84)90197-9.","journal-title":"Peptides"},{"key":"1073_CR45","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/0006-291X(89)92800-3","volume":"158","author":"EJ Goetzl","year":"1989","unstructured":"Goetzl EJ, Sreedharan SP, Turck CW, Bridenbaugh R, Malfroy B: Preferential cleavage of amino- and carboxyl-terminal oligopeptides from vasoactive intestinal polypeptide by human recombinant enkephalinase (neutral endopeptidase, EC 3.4.24.11). Biochem Biophys Res Commun. 1989, 158: 850-4. 10.1016\/0006-291X(89)92800-3.","journal-title":"Biochem Biophys Res Commun"},{"key":"1073_CR46","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0022-3565(25)24227-6","volume":"244","author":"GH Caughey","year":"1988","unstructured":"Caughey GH, Leidig F, Viro NF, Nadel JA: Substance P and vasoactive intestinal peptide degradation by mast cell tryptase and chymase. J Pharmacol Exp Ther. 1988, 244: 133-7.","journal-title":"J Pharmacol Exp Ther"},{"key":"1073_CR47","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1172\/JCI117280","volume":"93","author":"CM Lilly","year":"1994","unstructured":"Lilly CM, Kobzik L, Hall AE, Drazen JM: Effects of chronic airway inflammation on the activity and enzymatic inactivation of neuropeptides in guinea pig lungs. J Clin Invest. 1994, 93: 2667-74. 10.1172\/JCI117280.","journal-title":"J Clin Invest"},{"key":"1073_CR48","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0167-0115(02)00099-X","volume":"108","author":"M Laburthe","year":"2002","unstructured":"Laburthe M, Couvineau A: Molecular pharmacology and structure of VPAC Receptors for VIP and PACAP. Regul Pept. 2002, 108: 165-173. 10.1016\/S0167-0115(02)00099-X.","journal-title":"Regul Pept"},{"key":"1073_CR49","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/S0026-895X(25)09771-8","volume":"34","author":"SH Francis","year":"1988","unstructured":"Francis SH, Noblett BD, Todd BW, Wells JN, Corbin JD: Relaxation of vascular and tracheal smooth muscle by cyclic nucleotide analogs that preferentially activate purified cGMP-dependent protein kinase. Mol Pharmacol. 1988, 34: 506-17.","journal-title":"Mol Pharmacol"},{"key":"1073_CR50","doi-asserted-by":"crossref","first-page":"301","DOI":"10.2170\/jjphysiol.48.301","volume":"48","author":"A Arimura","year":"1998","unstructured":"Arimura A: Perspectives on pituitary adenylate cyclase activating polypeptide (PACAP) in the neuroendocrine, endocrine, and nervous systems. Jpn J Physiol. 1998, 48: 301-31. 10.2170\/jjphysiol.48.301.","journal-title":"Jpn J Physiol"},{"key":"1073_CR51","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0022-3565(25)23913-1","volume":"239","author":"JR Carstairs","year":"1986","unstructured":"Carstairs JR, Barnes PJ: Visualization of vasoactive intestinal peptide receptors in human and guinea pig lung. J Pharmacol Exp Ther. 1986, 239: 249-255.","journal-title":"J Pharmacol Exp Ther"},{"key":"1073_CR52","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1111\/j.1365-2567.2007.02705.x","volume":"123","author":"M Kulka","year":"2008","unstructured":"Kulka M, Sheen CH, Tancowny BP, Grammer LC, Schleimer RP: Neuropeptides activate human mast cell degranulation and chemokine production. Immunology. 2008, 123: 398-410. 10.1111\/j.1365-2567.2007.02705.x.","journal-title":"Immunology"},{"key":"1073_CR53","doi-asserted-by":"crossref","first-page":"4154","DOI":"10.4049\/jimmunol.173.6.4154","volume":"173","author":"I Harfi","year":"2004","unstructured":"Harfi I, D'Hondt S, Corazza F, Sariban E: Regulation of human polymorphonuclear leukocytes functions by the neuropeptide pituitary adenylate cyclase-activating polypeptide after activation of MAPKs. J Immunol. 2004, 173: 4154-63.","journal-title":"J Immunol"},{"key":"1073_CR54","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1749-6632.2000.tb06950.x","volume":"921","author":"ML Lara-Marquez","year":"2000","unstructured":"Lara-Marquez ML, O'Dorisio MS, Karacay B: Vasoactive intestinal peptide (VIP) receptor type 2 (VPAC2) is the predominant receptor expressed in human thymocytes. Ann NY Acad Sci. 2000, 921: 45-54. 10.1111\/j.1749-6632.2000.tb06950.x.","journal-title":"Ann NY Acad Sci"},{"key":"1073_CR55","doi-asserted-by":"crossref","first-page":"4685","DOI":"10.4049\/jimmunol.162.8.4685","volume":"162","author":"M Delgado","year":"1999","unstructured":"Delgado M, Munoz-Elias EJ, Gomariz RP, Ganea D: Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide prevent inducible nitric oxide synthase transcription in macrophages by inhibiting NF-kappa B and IFN regulatory factor 1 activation. J Immunol. 1999, 162: 4685-96.","journal-title":"J Immunol"},{"key":"1073_CR56","doi-asserted-by":"crossref","first-page":"3071","DOI":"10.4049\/jimmunol.163.6.3071","volume":"163","author":"Y Delneste","year":"1999","unstructured":"Delneste Y, Herbault N, Galea B, Magistrelli G, Bazin I, Bonnefoy JY, Jeannin P: Vasoactive intestinal peptide synergizes with TNF-alpha in inducing human dendritic cell maturation. J Immunol. 1999, 163: 3071-5.","journal-title":"J Immunol"},{"key":"1073_CR57","doi-asserted-by":"crossref","first-page":"13854","DOI":"10.1073\/pnas.241503798","volume":"98","author":"EJ Goetzl","year":"2001","unstructured":"Goetzl EJ, Voice JK, Shen S, Dorsam G, Kong Y, West KM, Morrison CF, Harmar AJ: Enhanced delayed-type hypersensitivity and diminished immediate-type hypersensitivity in mice lacking the inducible VPAC2 receptor for vasoactive intestinal peptide. Proc Natl Acad Sci USA. 2001, 98: 13854-13859. 10.1073\/pnas.241503798.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1073_CR58","doi-asserted-by":"crossref","first-page":"308","DOI":"10.4049\/jimmunol.170.1.308","volume":"170","author":"JK Voice","year":"2003","unstructured":"Voice JK, Grinninger C, Kong Y, Bangale Y, Paul S, Goetzl EJ: Roles of vasoactive intestinal peptide (VIP) in the expression of different immune phenotypes by wild-type mice and T cell-targeted type II VIP receptor transgenic mice. J Immunol. 2003, 170: 308-314.","journal-title":"J Immunol"},{"key":"1073_CR59","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1016\/S0140-6736(83)91272-2","volume":"2","author":"A Morice","year":"1983","unstructured":"Morice A, Unwin RJ, Sever PS: Vasoactive intestinal peptide causes bronchodilatation and protects against histamine-induced bronchoconstriction in asthmatic subjects. Lancet. 1983, 2: 1225-7. 10.1016\/S0140-6736(83)91272-2.","journal-title":"Lancet"},{"key":"1073_CR60","first-page":"H1300","volume":"263","author":"JT Colston","year":"1992","unstructured":"Colston JT, Freeman GL: Beneficial influence of vasoactive intestinal peptide on ventriculovascular coupling in closed-chest dogs. Am J Physiol. 1992, 263: H1300-5.","journal-title":"Am J Physiol"},{"key":"1073_CR61","first-page":"H1082","volume":"257","author":"DF Rigel","year":"1989","unstructured":"Rigel DF, Grupp IL, Balasubramaniam A, Grupp G: Contractile effects of cardiac neuropeptides in isolated canine atrial and ventricular muscles. Am J Physiol. 1989, 257: H1082-7.","journal-title":"Am J Physiol"},{"key":"1073_CR62","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1161\/01.RES.67.6.1323","volume":"67","author":"DF Rigel","year":"1990","unstructured":"Rigel DF, Lathrop DA: Vasoactive intestinal polypeptide facilitates atrioventricular nodal conduction and shortens atrial and ventricular refractory periods in conscious and anesthetized dogs. Circ Res. 1990, 67: 1323-33.","journal-title":"Circ Res"},{"key":"1073_CR63","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/0165-1838(92)90023-A","volume":"40","author":"RJ Henning","year":"1992","unstructured":"Henning RJ: Vagal stimulation during muscarinic and beta-adrenergic blockade increases atrial contractility and heart rate. J Auton Nerv Syst. 1992, 40: 121-9. 10.1016\/0165-1838(92)90023-A.","journal-title":"J Auton Nerv Syst"},{"key":"1073_CR64","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1016\/S0008-6363(96)00155-1","volume":"32","author":"RJ Henning","year":"1996","unstructured":"Henning RJ, Feliciano L, Coers CM: Vagal nerve stimulation increases right ventricular contraction and relaxation and heart rate. Cardiovasc Res. 1996, 32: 846-53.","journal-title":"Cardiovasc Res"},{"key":"1073_CR65","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0002-8703(96)90408-1","volume":"132","author":"P Lucia","year":"1996","unstructured":"Lucia P, Caiola S, Coppola A, Maroccia E, Belli M, Buongiorno A, De Martinis C: Early increase of vasoactive intestinal peptide in acute myocardial infarction. Am Heart J. 1996, 132: 187-9. 10.1016\/S0002-8703(96)90408-1.","journal-title":"Am Heart J"},{"key":"1073_CR66","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1006\/pupt.2001.0306","volume":"14","author":"DA Groneberg","year":"2001","unstructured":"Groneberg DA, Springer J, Fischer A: Vasoactive intestinal polypeptide as mediator of asthma. Pulm Pharmacol Ther. 2001, 14: 391-401. 10.1006\/pupt.2001.0306.","journal-title":"Pulm Pharmacol Ther"},{"key":"1073_CR67","first-page":"406","volume":"96","author":"Y Hamasaki","year":"1983","unstructured":"Hamasaki Y, Saga T, Mojarad M, Said SI: Vasoactive intestinal peptide counteracts leukotriene D4-induced contractions of guinea pig trachea, lung, and pulmonary artery. Trans Assoc Am Physicians. 1983, 96: 406-11.","journal-title":"Trans Assoc Am Physicians"},{"key":"1073_CR68","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1152\/jappl.1986.61.4.1322","volume":"61","author":"JB Palmer","year":"1986","unstructured":"Palmer JB, Cuss FM, Barnes PJ: VIP and PHM and their role in nonadrenergic inhibitory responses in isolated human airways. J Appl Physiol. 1986, 61: 1322-8.","journal-title":"J Appl Physiol"},{"key":"1073_CR69","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/labinvest.3780283","volume":"81","author":"DA Groneberg","year":"2001","unstructured":"Groneberg DA, Hartmann P, Dinh QT, Fischer A: Expression and distribution of vasoactive intestinal polypeptide receptor VPAC(2) mRNA in human airways. Lab Invest. 2001, 81: 749-55. 10.1038\/labinvest.3780283.","journal-title":"Lab Invest"},{"key":"1073_CR70","first-page":"531","volume":"124","author":"SJ Coles","year":"1981","unstructured":"Coles SJ, Said SI, Reid LM: Inhibition by vasoactive intestinal peptide of glycoconjugate and lysozyme secretion by human airways in vitro. Am Rev Respir Dis. 1981, 124: 531-6.","journal-title":"Am Rev Respir Dis"},{"key":"1073_CR71","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1172\/JCI114780","volume":"86","author":"JN Baraniuk","year":"1990","unstructured":"Baraniuk JN, Lundgren JD, Okayama M, Mullol J, Merida M, Shelhamer JH, Kaliner MA: Vasoactive intestinal peptide in human nasal mucosa. J Clin Invest. 1990, 86: 825-31. 10.1172\/JCI114780.","journal-title":"J Clin Invest"},{"key":"1073_CR72","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/j.1476-5381.1987.tb08992.x","volume":"91","author":"SE Webber","year":"1987","unstructured":"Webber SE, Widdicombe JG: The effect of vasoactive intestinal peptide on smooth muscle tone and mucus secretion from the ferret trachea. Br J Pharmacol. 1987, 91: 139-48.","journal-title":"Br J Pharmacol"},{"key":"1073_CR73","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1152\/jappl.1988.65.6.2537","volume":"65","author":"S Shimura","year":"1988","unstructured":"Shimura S, Sasaki T, Ikeda K, Sasaki H, Takishima T: VIP augments cholinergic-induced glycoconjugate secretion in tracheal submucosal glands. J Appl Physiol. 1988, 65: 2537-44.","journal-title":"J Appl Physiol"},{"key":"1073_CR74","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s00109-001-0291-5","volume":"80","author":"M Delgado","year":"2002","unstructured":"Delgado M, Abad C, Martinez C, Juarranz MG, Arranz A, Gomariz RP, Leceta J: Vasoactive intestinal peptide in the immune system: potential therapeutic role in inflammatory and autoimmune diseases. J Mol Med. 2002, 80: 16-24. 10.1007\/s00109-001-0291-5.","journal-title":"J Mol Med"},{"key":"1073_CR75","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/0014-2999(83)90012-2","volume":"88","author":"BJ Undem","year":"1983","unstructured":"Undem BJ, Dick EC, Buckner CK: Inhibition by vasoactive intestinal peptide of antigen-induced histamine release from guinea-pig minced lung. Eur J Pharmacol. 1983, 88: 247-50. 10.1016\/0014-2999(83)90012-2.","journal-title":"Eur J Pharmacol"},{"key":"1073_CR76","doi-asserted-by":"crossref","first-page":"3533","DOI":"10.4049\/jimmunol.142.10.3533","volume":"142","author":"MS O'Dorisio","year":"1989","unstructured":"O'Dorisio MS, Shannon BT, Fleshman DJ, Campolito LB: Identification of high affinity receptors for vasoactive intestinal peptide on human lymphocytes of B cell lineage. J Immunol. 1989, 142: 3533-6.","journal-title":"J Immunol"},{"key":"1073_CR77","first-page":"L151","volume":"259","author":"H Berisha","year":"1990","unstructured":"Berisha H, Foda H, Sakakibara H, Trotz M, Pakbaz H, Said SI: Vasoactive intestinal peptide prevents lung injury due to xanthine\/xanthine oxidase. Am J Physiol. 1990, 259: L151-5.","journal-title":"Am J Physiol"},{"key":"1073_CR78","doi-asserted-by":"crossref","first-page":"15371","DOI":"10.1016\/S0021-9258(18)55404-1","volume":"265","author":"BR Misra","year":"1990","unstructured":"Misra BR, Misra HP: Vasoactive intestinal peptide, a singlet oxygen quencher. J Biol Chem. 1990, 265: 15371-4.","journal-title":"J Biol Chem"},{"key":"1073_CR79","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1111\/j.1749-6632.2000.tb06954.x","volume":"921","author":"J Leceta","year":"2000","unstructured":"Leceta J, Gomariz RP, Martinez C, Abad C, Ganea D, Delgado M: Receptors and transcriptional factors involved in the anti-inflammatory activity of VIP and PACAP. Ann N Y Acad Sci. 2000, 921: 92-102. 10.1111\/j.1749-6632.2000.tb06954.x.","journal-title":"Ann N Y Acad Sci"},{"key":"1073_CR80","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1002\/jlb.64.6.828","volume":"64","author":"S Dunzendorfer","year":"1998","unstructured":"Dunzendorfer S, Meierhofer C, Wiedermann CJ: Signalling in neuropeptide-induced migration of human eosinophils. J Leukoc Biol. 1998, 64: 828-34.","journal-title":"J Leukoc Biol"},{"key":"1073_CR81","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1159\/000068324","volume":"10","author":"S Dunzendorfer","year":"2002","unstructured":"Dunzendorfer S, Feistritzer C, Enrich B, Wiedermann CJ: Neuropeptide-induced inhibition of IL-16 release from eosinophils. Neuroimmunomodulation. 2002, 10: 217-23. 10.1159\/000068324. 2003","journal-title":"Neuroimmunomodulation"},{"issue":"5","key":"1073_CR82","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S1471-4906(03)00069-3","volume":"24","author":"M Delgado","year":"2003","unstructured":"Delgado M: VIP: a very important peptide in T helper differentiation. Trends Immunol. 2003, 24 (5): 221-4. 10.1016\/S1471-4906(03)00069-3.","journal-title":"Trends Immunol"},{"key":"1073_CR83","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/S0967-2109(01)00126-0","volume":"10","author":"S Gunaydin","year":"2002","unstructured":"Gunaydin S, Imai Y, Takanashi Y, Seo K, Hagino I, Chang D, Shinoka T: The effects of vasoactive intestinal peptide on monocrotaline induced pulmonary hypertensive rabbits following cardiopulmonary bypass: a comparative study with isoproteronol and nitroglycerine. Cardiovasc Surg. 2002, 10: 138-45. 10.1016\/S0967-2109(01)00126-0.","journal-title":"Cardiovasc Surg"},{"key":"1073_CR84","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1196\/annals.1418.014","volume":"1144","author":"SI Said","year":"2008","unstructured":"Said SI: The vasoactive intestinal peptide gene is a key modulator of pulmonary vascular remodeling and inflammation. Ann N Y Acad Sci. 2008, 1144: 148-53. 10.1196\/annals.1418.014.","journal-title":"Ann N Y Acad Sci"},{"key":"1073_CR85","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1161\/CIRCULATIONAHA.106.681718","volume":"115","author":"SI Said","year":"2007","unstructured":"Said SI, Hamidi SA, Dickman KG, Szema AM, Lyubsky S, Lin RZ, Jiang YP, Chen JJ, Waschek JA, Kort S: Moderate pulmonary arterial hypertension in male mice lacking the vasoactive intestinal peptide gene. Circulation. 2007, 115: 1260-8.","journal-title":"Circulation"},{"key":"1073_CR86","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1097\/00005344-199012000-00021","volume":"16","author":"JJ Popma","year":"1990","unstructured":"Popma JJ, Smitherman TC, Bedotto JB, Eichhorn EJ, Said SI, Dehmer GJ: Direct coronary vasodilation induced by intracoronary vasoactive intestinal peptide. J Cardiovasc Pharmacol. 1990, 16: 1000-6. 10.1097\/00005344-199012000-00021.","journal-title":"J Cardiovasc Pharmacol"},{"key":"1073_CR87","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1016\/0002-9149(87)90619-9","volume":"60","author":"LL Frase","year":"1987","unstructured":"Frase LL, Gaffney FA, Lane LD, Buckey JC, Said SI, Blomqvist CG, Krejs GJ: Cardiovascular effects of vasoactive intestinal peptide in healthy subjects. Am J Cardiol. 1987, 60: 1356-61. 10.1016\/0002-9149(87)90619-9.","journal-title":"Am J Cardiol"},{"key":"1073_CR88","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1378\/chest.124.2.474","volume":"124","author":"JB Soriano","year":"2003","unstructured":"Soriano JB, Davis KJ, Coleman B, Visick G, Mannino D, Pride NB: The proportional Venn diagram of obstructive lung disease: two approximations from the United States and the United Kingdom. Chest. 2003, 124: 474-81. 10.1378\/chest.124.2.474.","journal-title":"Chest"},{"key":"1073_CR89","doi-asserted-by":"crossref","first-page":"501","DOI":"10.2174\/138945011794751483","volume":"12","author":"E Zakynthinos","year":"2011","unstructured":"Zakynthinos E, Daniil Z, Papanikolaou G, Makris D: Pulmonary Hypertension in COPD: Pathophysiology and Therapeutic Targets. Curr Drug Targets. 2011, 12: 501-13. 10.2174\/138945011794751483.","journal-title":"Curr Drug Targets"},{"key":"1073_CR90","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1183\/09031936.00097109","volume":"35","author":"SI Said","year":"2010","unstructured":"Said SI, Hamidi SA, Gonzalez Bosc L: Asthma and pulmonary arterial hypertension: do they share a key mechanism of pathogenesis?. Eur Respir J. 2010, 35: 730-4. 10.1183\/09031936.00097109.","journal-title":"Eur Respir J"},{"key":"1073_CR91","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1183\/09031936.03.00038903","volume":"22","author":"P Dorfm\u00fcller","year":"2003","unstructured":"Dorfm\u00fcller P, Perros F, Balabanian K, Humbert M: Inflammation in pulmonary arterial hypertension. Eur Respir J. 2003, 22: 358-63.","journal-title":"Eur Respir J"},{"key":"1073_CR92","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1146\/annurev.physiol.59.1.89","volume":"59","author":"KR Stenmark","year":"1997","unstructured":"Stenmark KR, Mecham RP: Cellular and molecular mechanisms of pulmonary vascular remodeling. Annu Rev Physiol. 1997, 59: 89-144. 10.1146\/annurev.physiol.59.1.89.","journal-title":"Annu Rev Physiol"},{"key":"1073_CR93","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1152\/physiol.00035.2004","volume":"20","author":"RJ Homer","year":"2005","unstructured":"Homer RJ, Elias JA: Airway remodeling in asthma: therapeutic implications of mechanisms. Physiology (Bethesda). 2005, 20: 28-35.","journal-title":"Physiology (Bethesda)"},{"key":"1073_CR94","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.regpep.2003.10.002","volume":"117","author":"S Sergejeva","year":"2004","unstructured":"Sergejeva S, Hoshino H, Yoshihara S, Kashimoto K, L\u00f6tvall J, Lind\u00e9n A: A synthetic VIP peptide analogue inhibits neutrophil recruitment in rat airways in vivo. Regul Pept. 2004, 117: 149-54. 10.1016\/j.regpep.2003.10.002.","journal-title":"Regul Pept"},{"key":"1073_CR95","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1111\/j.1432-1033.2004.04086.x","volume":"271","author":"S Onoue","year":"2004","unstructured":"Onoue S, Ohmori Y, Endo K, Yamada S, Kimura R, Yajima T: Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide attenuate the cigarette smoke extract-induced apoptotic death of rat alveolar L2 cells. Eur JBiochem. 2004, 271: 1757-67. 10.1111\/j.1432-1033.2004.04086.x.","journal-title":"Eur JBiochem"},{"key":"1073_CR96","doi-asserted-by":"crossref","first-page":"3107","DOI":"10.1016\/j.peptides.2006.08.004","volume":"27","author":"CX Guan","year":"2006","unstructured":"Guan CX, Zhang M, Qin XQ, Cui YR, Luo ZQ, Bai HB, Fang X: Vasoactive intestinal peptide enhances wound healing and proliferation of human bronchial epithelial cells. Peptides. 2006, 27: 3107-14. 10.1016\/j.peptides.2006.08.004.","journal-title":"Peptides"},{"key":"1073_CR97","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.peptides.2009.09.032","volume":"31","author":"S Misaka","year":"2010","unstructured":"Misaka S, Aoki Y, Karaki S, Kuwahara A, Mizumoto T, Onoue S, Yamada S: Inhalable powder formulation of a stabilized vasoactive intestinal peptide (VIP) derivative: anti-inflammatory effect in experimental asthmatic rats. Peptides. 2010, 31: 72-8. 10.1016\/j.peptides.2009.09.032.","journal-title":"Peptides"},{"key":"1073_CR98","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.peptides.2010.10.021","volume":"32","author":"S Misaka","year":"2011","unstructured":"Misaka S, Sato H, Aoki Y, Mizumoto T, Onoue S, Yamada S: Novel vasoactive intestinal peptide derivatives with improved stability protect rat alveolar L2 cells from cigarette smoke-induced cytotoxicity and apoptosis. Peptides. 2011, 32: 401-7. 10.1016\/j.peptides.2010.10.021.","journal-title":"Peptides"},{"key":"1073_CR99","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1586\/14779072.3.4.565","volume":"3","author":"I Rubinstein","year":"2005","unstructured":"Rubinstein I: Human VIP-alpha: an emerging biologic response modifier to treat primary pulmonary hypertension. Expert Rev Cardiovasc Ther. 2005, 3: 565-9. 10.1586\/14779072.3.4.565.","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"1073_CR100","first-page":"107","volume":"13","author":"DR Bolin","year":"1996","unstructured":"Bolin DR, Cottrell J, Garippa R, Rinaldi N, Senda R, Simko B, O'Donnell M: Comparison of cyclic and linear analogs of vasoactive intestinal peptide. Drug Des Discov. 1996, 13: 107-14.","journal-title":"Drug Des Discov"},{"key":"1073_CR101","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1007\/s002100100458","volume":"364","author":"DT Schmidt","year":"2001","unstructured":"Schmidt DT, R\u00fchlmann E, Waldeck B, Branscheid D, Luts A, Sundler F, Rabe KF: The effect of the vasoactive intestinal polypeptide agonist Ro 25-1553 on induced tone in isolated human airways and pulmonary artery. Naunyn Schmiedebergs Arch Pharmacol. 2001, 364: 314-20. 10.1007\/s002100100458.","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"1073_CR102","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1136\/thorax.58.3.217","volume":"58","author":"A Lind\u00e9n","year":"2003","unstructured":"Lind\u00e9n A, Hansson L, Andersson A, Palmqvist M, Arvidsson P, L\u00f6fdahl CG, Larsson P, L\u00f6tvall J: Bronchodilation by an inhaled VPAC(2) receptor agonist in patients with stable asthma. Thorax. 2003, 58: 217-21.","journal-title":"Thorax"}],"container-title":["Respiratory Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1465-9921-12-45.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1465-9921-12-45\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1465-9921-12-45.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T00:47:33Z","timestamp":1741135653000},"score":1,"resource":{"primary":{"URL":"http:\/\/respiratory-research.biomedcentral.com\/articles\/10.1186\/1465-9921-12-45"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12]]},"references-count":102,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["1073"],"URL":"https:\/\/doi.org\/10.1186\/1465-9921-12-45","relation":{},"ISSN":["1465-993X"],"issn-type":[{"value":"1465-993X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,12]]},"article-number":"45"}}